search
Back to results

The Effects of Scalp Block With Bupivacaine Versus Levobupivacaine

Primary Purpose

Hypertension

Status
Completed
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Levobupivacaine
Bupivacaine
placebo
Sponsored by
Uludag University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypertension focused on measuring anaesthesia, local anaesthesia, hemodynamics, bupivacaine, levobupivacaine

Eligibility Criteria

18 Years - 85 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • American Society of Anesthesiologists (ASA) Physical Status classification system 1-2

Exclusion Criteria:

  • Uncontrolled hypertension, arrhythmia, diabetes mellitus or coagulopathy, coronary artery disease or a proven or suspected allergy to bupivacaine or levobupivacaine

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm Type

    Experimental

    Active Comparator

    Active Comparator

    Arm Label

    bupivacaine,levobupivacaine

    levobupivacaine

    bupivacaine

    Arm Description

    20 ml of 0.5% bupivacaine 20 ml of 0.5% levobupivacaine

    20 ml of 0.5% levobupivacaine saline as a placebo

    20 ml of 0.5% bupivacaine saline as a placebo

    Outcomes

    Primary Outcome Measures

    Change in Mean Arterial Pressure

    Secondary Outcome Measures

    Full Information

    First Posted
    July 2, 2015
    Last Updated
    December 7, 2017
    Sponsor
    Uludag University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02497040
    Brief Title
    The Effects of Scalp Block With Bupivacaine Versus Levobupivacaine
    Official Title
    Effects of Scalp Block With Bupivacaine Versus Levobupivacaine on Haemodynamic Response to Head Pinning and Efficacy on Postoperative Analgesia
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    December 2017
    Overall Recruitment Status
    Completed
    Study Start Date
    March 2008 (undefined)
    Primary Completion Date
    March 2009 (Actual)
    Study Completion Date
    April 2009 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Uludag University

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Ninety American Society of Anesthesiologists (ASA) Physical Status classification system I-II patients were recruited for a randomised, placebo-controlled, double-blind study and were randomly divided into three groups to receive either 20 ml of 0.5% bupivacaine (Group B; n=30), 20 ml of 0.5% levobupivacaine (Group L; n=30) or saline as a placebo (Group C; n=30). Scalp block was performed 5 min before head pinning. The primary outcome of the study was mean arterial pressure (MAP) and secondary outcomes were heart rate (HR), visual analogue scale (VAS) scores, additional intraoperative and postoperative drug use. Postoperative pain was evaluated using a 10-cm visual analogue scale (VAS).
    Detailed Description
    Following approval from the Research Ethics Committee of the Medical Faculty of Uludağ University, (the date and protocol number assigned by this ethics committee were March 4, 2008 and 5/30, respectively),written informed consent was obtained from patients undergoing elective scheduled operations involving craniotomy during anaesthesia consultations. Ninety American Society of Anesthesiologists (ASA) Physical Status classification system I or II patients of either sex between 18-85 years of age were allocated to this randomised, prospective, placebo-controlled, double-blind study. The patients were randomly divided into three groups using a sealed-enveloped technique to receive either 20 ml of 0.5% bupivacaine (Group B (n=30)), 20 ml of 0.5% levobupivacaine (Group L (n=30)) or saline as a placebo (Group C (n=30)). Twenty-millilitre syringes for the block were prepared and numbered by a blinded assistant.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Hypertension
    Keywords
    anaesthesia, local anaesthesia, hemodynamics, bupivacaine, levobupivacaine

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 4
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantCare Provider
    Allocation
    Randomized
    Enrollment
    90 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    bupivacaine,levobupivacaine
    Arm Type
    Experimental
    Arm Description
    20 ml of 0.5% bupivacaine 20 ml of 0.5% levobupivacaine
    Arm Title
    levobupivacaine
    Arm Type
    Active Comparator
    Arm Description
    20 ml of 0.5% levobupivacaine saline as a placebo
    Arm Title
    bupivacaine
    Arm Type
    Active Comparator
    Arm Description
    20 ml of 0.5% bupivacaine saline as a placebo
    Intervention Type
    Drug
    Intervention Name(s)
    Levobupivacaine
    Other Intervention Name(s)
    chirocaine
    Intervention Description
    local injection
    Intervention Type
    Drug
    Intervention Name(s)
    Bupivacaine
    Other Intervention Name(s)
    marcaine
    Intervention Description
    local injection
    Intervention Type
    Drug
    Intervention Name(s)
    placebo
    Other Intervention Name(s)
    saline
    Intervention Description
    local injection
    Primary Outcome Measure Information:
    Title
    Change in Mean Arterial Pressure
    Time Frame
    220+-70 minutes

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    85 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: American Society of Anesthesiologists (ASA) Physical Status classification system 1-2 Exclusion Criteria: Uncontrolled hypertension, arrhythmia, diabetes mellitus or coagulopathy, coronary artery disease or a proven or suspected allergy to bupivacaine or levobupivacaine
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    hulya bilgin
    Organizational Affiliation
    uludag university anaesthesia and reanimation department
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    8942596
    Citation
    Pinosky ML, Fishman RL, Reeves ST, Harvey SC, Patel S, Palesch Y, Dorman BH. The effect of bupivacaine skull block on the hemodynamic response to craniotomy. Anesth Analg. 1996 Dec;83(6):1256-61. doi: 10.1097/00000539-199612000-00022.
    Results Reference
    background
    PubMed Identifier
    11426091
    Citation
    Agarwal A, Sinha PK, Pandey CM, Gaur A, Pandey CK, Kaushik S. Effect of a subanesthetic dose of intravenous ketamine and/or local anesthetic infiltration on hemodynamic responses to skull-pin placement: a prospective, placebo-controlled, randomized, double-blind study. J Neurosurg Anesthesiol. 2001 Jul;13(3):189-94. doi: 10.1097/00008506-200107000-00002.
    Results Reference
    background
    PubMed Identifier
    15817709
    Citation
    Costello TG, Cormack JR, Mather LE, LaFerlita B, Murphy MA, Harris K. Plasma levobupivacaine concentrations following scalp block in patients undergoing awake craniotomy. Br J Anaesth. 2005 Jun;94(6):848-51. doi: 10.1093/bja/aei135. Epub 2005 Apr 7.
    Results Reference
    background

    Learn more about this trial

    The Effects of Scalp Block With Bupivacaine Versus Levobupivacaine

    We'll reach out to this number within 24 hrs